探索CALD和非CALD女性对妊娠糖尿病低强度干预的行为和饮食反应
Kai Liu1,2,3, Georgia S Clarke1,2,3, Melissa Oxlad4
1Adelaide Medical School, The University of Adelaide, Adelaide 5005, Australia.
Nutrients
|October 29, 2025
概括
针对妊娠糖尿病 (GDM) 的文化定制的饮食建议在不同女性中显示出类似的坚持和满意度. 这支持广泛适用的产前饮食策略,强调包容性研究.
科学领域:
- 营养科学 营养科学
- 孕产妇健康 孕产妇健康
- 行为科学 行为科学
背景情况:
- 文化背景显著影响饮食习惯和健康干预态度.
- 有限的研究存在于文化和语言多样性 (CALD) 妇女的干预坚持.
- 妊娠期糖尿病 (GDM) 需要有效的饮食管理,特别是在多样化的人口中.
研究的目的:
- 为了探索在CALD中坚持,满意度和行为变化的差异,与接受GDM饮食干预的白人女性相比.
- 评估文化定制的饮食干预措施对GDM在不同女性中的可行性和可接受性.
主要方法:
- 一项随机对照可行性试验的二次分析,该试验涉及38名患有GDM的女性.
- 参与者被随机分配到个性化,文化定制的饮食咨询小组或标准护理.
- 数据包括行为变化问卷,利克特满意度/坚持度等级和24小时饮食回忆.
主要成果:
- 在干预组中,在CALD和非CALD妇女之间没有观察到显著的遵守差异 (CALD:8.10与非CALD:7.58) 或满意度 (CALD:7.85与非CALD:6.88).
- 所有干预参与者,无论文化背景如何,都被激励改变饮食.
- 在干预或标准护理组中,CALD和非CALD参与者之间的饮食摄入量没有差异.
结论:
- 对GDM进行低强度,个性化的饮食干预对于CALD和非CALD女性来说同样是可以接受和可行的.
- 研究结果表明,在产前护理中,有可能广泛应用饮食策略.
- 需要进一步的文化细微研究,以确保所有妇女的包容性和有效干预措施.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
631
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
631
Oral Hypoglycemic Agents: Biguanides and Glitazones
581
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
581
Diabetes: Management and Pharmacotherapy
858
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
858
Hypoglycemia and Glucagon
822
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
822


